After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

Help Black families facing dementia. Join SHARE, a clinical trial for support, health, activities, resources, and education.

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...

USC researchers have found a promising new brain scan marker that could better detect Alzheimer’s risk — but only for some.

NKGen Biotech, Inc. has announced the activation of two new clinical trial sites for its Phase 1/2a trial of troculeucel, a cryopreserved expanded autologous NK cell therapy for moderate Alzheimer ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson's disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...